Klin Med s.r.o.
- Address
- lock Available on a paid plan
Klin Med s.r.o. - Metabolic and Liver Disease Research
Klin Med s.r.o. is a clinical research facility specializing in metabolic and hepatic disorders, with a particular emphasis on investigating novel therapeutic approaches for chronic liver conditions. The center has established expertise in conducting complex Phase 2 clinical trials that evaluate innovative treatments for progressive liver disease.
- Non-alcoholic steatohepatitis (NASH) and liver fibrosis research
- Advanced metabolic disease management and intervention
- Long-term safety and efficacy studies in hepatic disorders
The research center focuses on evaluating breakthrough therapies targeting NASH resolution and prevention of fibrosis progression in patients with precirrhotic disease. Their clinical trial portfolio demonstrates commitment to addressing the growing epidemic of metabolic liver disease through rigorous assessment of novel pharmacological interventions aimed at reversing liver damage and improving patient outcomes.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Mirum Pharmaceuticals Inc.2active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Mirum Pharmaceuticals Inc.2trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 634 other sites in Czechia
Therapeutic Area Benchmark — Czechia
Select a therapeutic area to compare against other sites in Czechia.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Czechia
Market Share
Country: Czechia
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Klin Med s.r.o.
lock Showing 1 of 4 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 2b Randomized, Double-Blind Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Efinopegdutide (MK-6024) in Adults with Precirrhotic Nonalcoholic Steatohepatitis | Merck Sharp & Dohme LLC | Phase II | Not Recruiting | Sep 2023 | Dec 2025 |
IMP list
lock Showing 1 of 5 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Bjt-778 | 2 | Unknown | 2025-08-28 | 2026-02-26 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.